Not currently recruiting at University of California Health
A Study of Felzartamab in Participants With Lupus Nephritis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- HI-Bio, A Biogen Company
- ID
- NCT06064929
- Phase
- Phase 1 Lupus Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated